We observed reassuring homogeneity of the results obtained; nearly all of the samples amplified the SMN1 gene in the same cycle, whilst control cases and cases suspected of SMA were correctly identified as pathological. The gene discussed is SMN1; the disease is proximal spinal muscular atrophy.